ReP USP - Resultado da busca

Artigo de periodico
Effect of Crocus sativus L. (saffron) and crocin in the treatment of patients with type-2 diabetes mellitus: a systematic review and meta-analysis (2024)
Amatto, Pedro de Padua G.; Chaves, Lucas; Braga, Giovana Graça; Carmona, Fabio ; Pereira, Ana Maria Soares
Source: Journal of Ethnopharmacology. Unidades: FMRP, FCFRP
Subjects: AÇAFRÃO, DIABETES MELLITUS, FATORES DE RISCO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMATTO, Pedro de Padua G. et al. Effect of Crocus sativus L. (saffron) and crocin in the treatment of patients with type-2 diabetes mellitus: a systematic review and meta-analysis. Journal of Ethnopharmacology, v. 319, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.jep.2023.117255. Acesso em: 16 nov. 2024.
APA
Amatto, P. de P. G., Chaves, L., Braga, G. G., Carmona, F., & Pereira, A. M. S. (2024). Effect of Crocus sativus L. (saffron) and crocin in the treatment of patients with type-2 diabetes mellitus: a systematic review and meta-analysis. Journal of Ethnopharmacology, 319. doi:10.1016/j.jep.2023.117255
NLM
Amatto P de PG, Chaves L, Braga GG, Carmona F, Pereira AMS. Effect of Crocus sativus L. (saffron) and crocin in the treatment of patients with type-2 diabetes mellitus: a systematic review and meta-analysis [Internet]. Journal of Ethnopharmacology. 2024 ; 319[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jep.2023.117255
Vancouver
Amatto P de PG, Chaves L, Braga GG, Carmona F, Pereira AMS. Effect of Crocus sativus L. (saffron) and crocin in the treatment of patients with type-2 diabetes mellitus: a systematic review and meta-analysis [Internet]. Journal of Ethnopharmacology. 2024 ; 319[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jep.2023.117255
Artigo de periodico
Age, gender, and 11 comorbidities as risk factors associated with COVID-19 mortality: a retrospective cohort including 1.8 million individuals (2023)
Cruz, Jonas Carneiro ; Martins, Carolina Kakiuthi; Katchborian Neto, Albert; Araújo, Cristiano Miranda de; Dellalibera-Joviliano, Renata; Barbosa Junior, Fernando
Source: Journal of Toxicology and Environmental Health, Part A. Unidade: FCFRP
Subjects: FATORES ETÁRIOS, IDOSOS, CRIANÇAS, COVID-19, DIABETES MELLITUS, HOSPITALIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZ, Jonas Carneiro et al. Age, gender, and 11 comorbidities as risk factors associated with COVID-19 mortality: a retrospective cohort including 1.8 million individuals. Journal of Toxicology and Environmental Health, Part A, v. 86, n. 14, p. 491-500, 2023Tradução . . Disponível em: https://doi.org/10.1080/15287394.2023.2223598. Acesso em: 16 nov. 2024.
APA
Cruz, J. C., Martins, C. K., Katchborian Neto, A., Araújo, C. M. de, Dellalibera-Joviliano, R., & Barbosa Junior, F. (2023). Age, gender, and 11 comorbidities as risk factors associated with COVID-19 mortality: a retrospective cohort including 1.8 million individuals. Journal of Toxicology and Environmental Health, Part A, 86( 14), 491-500. doi:10.1080/15287394.2023.2223598
NLM
Cruz JC, Martins CK, Katchborian Neto A, Araújo CM de, Dellalibera-Joviliano R, Barbosa Junior F. Age, gender, and 11 comorbidities as risk factors associated with COVID-19 mortality: a retrospective cohort including 1.8 million individuals [Internet]. Journal of Toxicology and Environmental Health, Part A. 2023 ; 86( 14): 491-500.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1080/15287394.2023.2223598
Vancouver
Cruz JC, Martins CK, Katchborian Neto A, Araújo CM de, Dellalibera-Joviliano R, Barbosa Junior F. Age, gender, and 11 comorbidities as risk factors associated with COVID-19 mortality: a retrospective cohort including 1.8 million individuals [Internet]. Journal of Toxicology and Environmental Health, Part A. 2023 ; 86( 14): 491-500.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1080/15287394.2023.2223598
Artigo de periodico
Influence of glucose supplementation on biofilm formation of Candida albicans and Candida glabrata isolated from diabetic and non-diabetic individuals (2022)
Domingues, Pedro Castania Amadio; Oliveira, Viviane de Cássia ; Bim, Felipe Lazarini ; Garbellini, Carolina Patricia Aires ; Santos, André Pereira dos ; Castro, Denise Tornavoi de ; Silva-Lovato, Cláudia Helena ; Andrade, Denise de ; Watanabe, Evandro
Source: Archives of Oral Biology. Unidades: FORP, FCFRP, EEFERP, EERP
Subjects: ANTIFÚNGICOS, BIOFILMES, CANDIDA ALBICANS, DIABETES MELLITUS, SUPLEMENTOS DIETÉTICOS, GLICOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOMINGUES, Pedro Castania Amadio et al. Influence of glucose supplementation on biofilm formation of Candida albicans and Candida glabrata isolated from diabetic and non-diabetic individuals. Archives of Oral Biology, v. 134, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.archoralbio.2021.105339. Acesso em: 16 nov. 2024.
APA
Domingues, P. C. A., Oliveira, V. de C., Bim, F. L., Garbellini, C. P. A., Santos, A. P. dos, Castro, D. T. de, et al. (2022). Influence of glucose supplementation on biofilm formation of Candida albicans and Candida glabrata isolated from diabetic and non-diabetic individuals. Archives of Oral Biology, 134, 1-9. doi:10.1016/j.archoralbio.2021.105339
NLM
Domingues PCA, Oliveira V de C, Bim FL, Garbellini CPA, Santos AP dos, Castro DT de, Silva-Lovato CH, Andrade D de, Watanabe E. Influence of glucose supplementation on biofilm formation of Candida albicans and Candida glabrata isolated from diabetic and non-diabetic individuals [Internet]. Archives of Oral Biology. 2022 ; 134 1-9.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.archoralbio.2021.105339
Vancouver
Domingues PCA, Oliveira V de C, Bim FL, Garbellini CPA, Santos AP dos, Castro DT de, Silva-Lovato CH, Andrade D de, Watanabe E. Influence of glucose supplementation on biofilm formation of Candida albicans and Candida glabrata isolated from diabetic and non-diabetic individuals [Internet]. Archives of Oral Biology. 2022 ; 134 1-9.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.archoralbio.2021.105339
Dissertação (Mestrado)
Estudo das demandas educacionais necessárias para a autogestão do diabetes de pessoas que utilizam a insulina: avaliação qualitativa e revisão sistemática (2022)
Lemos, Carla Assad; Pereira, Leonardo Régis Leira (Orientador)
Unidade: FCFRP
Subjects: DIABETES MELLITUS, INSULINA, AUTOCUIDADO, USO DE MEDICAMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEMOS, Carla Assad. Estudo das demandas educacionais necessárias para a autogestão do diabetes de pessoas que utilizam a insulina: avaliação qualitativa e revisão sistemática. 2022. Dissertação (Mestrado) – Universidade de São Paulo, Ribeirão Preto, 2022. Disponível em: https://www.teses.usp.br/teses/disponiveis/60/60137/tde-21062022-112051/. Acesso em: 16 nov. 2024.
APA
Lemos, C. A. (2022). Estudo das demandas educacionais necessárias para a autogestão do diabetes de pessoas que utilizam a insulina: avaliação qualitativa e revisão sistemática (Dissertação (Mestrado). Universidade de São Paulo, Ribeirão Preto. Recuperado de https://www.teses.usp.br/teses/disponiveis/60/60137/tde-21062022-112051/
NLM
Lemos CA. Estudo das demandas educacionais necessárias para a autogestão do diabetes de pessoas que utilizam a insulina: avaliação qualitativa e revisão sistemática [Internet]. 2022 ;[citado 2024 nov. 16 ] Available from: https://www.teses.usp.br/teses/disponiveis/60/60137/tde-21062022-112051/
Vancouver
Lemos CA. Estudo das demandas educacionais necessárias para a autogestão do diabetes de pessoas que utilizam a insulina: avaliação qualitativa e revisão sistemática [Internet]. 2022 ;[citado 2024 nov. 16 ] Available from: https://www.teses.usp.br/teses/disponiveis/60/60137/tde-21062022-112051/
Artigo de periodico
Vibration therapy as an effective approach to improve bone healing in diabetic rats (2022)
Campos, Maysa de Souza; Volpon, Jose Batista ; Ximenez, João Paulo Bianchi ; Guimarães, Ana Paula Franttini Garcia Moreno; Dalloul, Christopher E.; Sousa Neto, Manoel Damião de ; Segato, Raquel Assed Bezerra ; Kacena, Melissa A.; Zamarioli, Ariane
Source: Frontiers in Endocrinology. Unidades: FMRP, FCFRP, FORP, FFCLRP
Subjects: CALO ÓSSEO, DIABETES MELLITUS, CICATRIZAÇÃO, FRATURAS, MICROTOMOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Maysa de Souza et al. Vibration therapy as an effective approach to improve bone healing in diabetic rats. Frontiers in Endocrinology, v. 13, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.3389/fendo.2022.909317. Acesso em: 16 nov. 2024.
APA
Campos, M. de S., Volpon, J. B., Ximenez, J. P. B., Guimarães, A. P. F. G. M., Dalloul, C. E., Sousa Neto, M. D. de, et al. (2022). Vibration therapy as an effective approach to improve bone healing in diabetic rats. Frontiers in Endocrinology, 13, 1-14. doi:10.3389/fendo.2022.909317
NLM
Campos M de S, Volpon JB, Ximenez JPB, Guimarães APFGM, Dalloul CE, Sousa Neto MD de, Segato RAB, Kacena MA, Zamarioli A. Vibration therapy as an effective approach to improve bone healing in diabetic rats [Internet]. Frontiers in Endocrinology. 2022 ; 13 1-14.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fendo.2022.909317
Vancouver
Campos M de S, Volpon JB, Ximenez JPB, Guimarães APFGM, Dalloul CE, Sousa Neto MD de, Segato RAB, Kacena MA, Zamarioli A. Vibration therapy as an effective approach to improve bone healing in diabetic rats [Internet]. Frontiers in Endocrinology. 2022 ; 13 1-14.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fendo.2022.909317
Artigo de periodico
Variables associated with adherence to the treatment of type 2 diabetes mellitus among elderly people (2022)
Oliveira, Rinaldo Eduardo Machado de; Ueta, Julieta Mieko ; Franco, Laércio Joel
Source: Diabetology International. Unidades: FMRP, FCFRP
Subjects: DIABETES MELLITUS, IDOSOS, ADESÃO À MEDICAÇÃO, SAÚDE DA FAMÍLIA, PREVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Rinaldo Eduardo Machado de e UETA, Julieta Mieko e FRANCO, Laércio Joel. Variables associated with adherence to the treatment of type 2 diabetes mellitus among elderly people. Diabetology International, v. 13, p. 160-168, 2022Tradução . . Disponível em: https://doi.org/10.1007/s13340-021-00518-1. Acesso em: 16 nov. 2024.
APA
Oliveira, R. E. M. de, Ueta, J. M., & Franco, L. J. (2022). Variables associated with adherence to the treatment of type 2 diabetes mellitus among elderly people. Diabetology International, 13, 160-168. doi:10.1007/s13340-021-00518-1
NLM
Oliveira REM de, Ueta JM, Franco LJ. Variables associated with adherence to the treatment of type 2 diabetes mellitus among elderly people [Internet]. Diabetology International. 2022 ; 13 160-168.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s13340-021-00518-1
Vancouver
Oliveira REM de, Ueta JM, Franco LJ. Variables associated with adherence to the treatment of type 2 diabetes mellitus among elderly people [Internet]. Diabetology International. 2022 ; 13 160-168.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s13340-021-00518-1
Artigo de periodico
Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil (2022)
Peres, Heverton Alves; Martinez, Edson Zangiacomi ; Viana, Carlos Manuel; Pereira, Leonardo Régis Leira
Source: Brazilian Journal of Pharmaceutical Sciences. Unidades: FMRP, FCFRP
Subjects: GLICEMIA, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Heverton Alves et al. Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil. Brazilian Journal of Pharmaceutical Sciences, v. 58, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902022e20985. Acesso em: 16 nov. 2024.
APA
Peres, H. A., Martinez, E. Z., Viana, C. M., & Pereira, L. R. L. (2022). Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil. Brazilian Journal of Pharmaceutical Sciences, 58, 1-13. doi:10.1590/s2175-97902022e20985
NLM
Peres HA, Martinez EZ, Viana CM, Pereira LRL. Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-13.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/s2175-97902022e20985
Vancouver
Peres HA, Martinez EZ, Viana CM, Pereira LRL. Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-13.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/s2175-97902022e20985
Artigo de periodico
Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control (2021)
Costa, Ana Carolina Conchon ; Benzi, Jhohann Richard de Lima ; Yamamoto, Priscila Akemi ; Freitas, Maria Cristina Foss de ; Paula, Francisco Jose Albuquerque de ; Zanelli, Cleslei Fernando; Lauretti, Gabriela Rocha ; Moraes, Natália Valadares
Source: British Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOCINÉTICA, DIABETES MELLITUS, DOR, HIPERGLICEMIA, FARMACOLOGIA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Ana Carolina Conchon et al. Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control. British Journal of Clinical Pharmacology, v. 87, n. 4, p. 1981-1989, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcp.14594. Acesso em: 16 nov. 2024.
APA
Costa, A. C. C., Benzi, J. R. de L., Yamamoto, P. A., Freitas, M. C. F. de, Paula, F. J. A. de, Zanelli, C. F., et al. (2021). Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control. British Journal of Clinical Pharmacology, 87( 4), 1981-1989. doi:10.1111/bcp.14594
NLM
Costa ACC, Benzi JR de L, Yamamoto PA, Freitas MCF de, Paula FJA de, Zanelli CF, Lauretti GR, Moraes NV. Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 4): 1981-1989.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bcp.14594
Vancouver
Costa ACC, Benzi JR de L, Yamamoto PA, Freitas MCF de, Paula FJA de, Zanelli CF, Lauretti GR, Moraes NV. Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 4): 1981-1989.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bcp.14594
Artigo de periodico
Hypoglycemic activity of aqueous extract of latex from Hancornia speciosa Gomes: a study in Zebrafish and in silico (2021)
Tomazi, Rosana; Figueira, Ângela Costa; Ferreira, Adriana Maciel; Ferreira, Diego Quaresma; Souza, Gisele Custódio de; Pinheiro, Wandson Braamcamp de Souza; Pinheiro Neto, José Rodrigues; Silva, Geilson Alcantara da; Lima, Henrique Barros de; Hage-Melim, Lorane Izabel da Silva; Pereira Filho, Arlindo César Matias ; Carvalho, José Carlos Tavares; Almeida, Sheylla Susan Moreira da Silva de
Source: Pharmaceuticals. Unidade: FCFRP
Subjects: GENTIANALES, PRODUTOS NATURAIS, EXTRATOS (FORMAS FARMACÊUTICAS), MODELOS ANIMAIS DE DOENÇAS, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOMAZI, Rosana et al. Hypoglycemic activity of aqueous extract of latex from Hancornia speciosa Gomes: a study in Zebrafish and in silico. Pharmaceuticals, v. 14, n. 9, p. 1-29, 2021Tradução . . Disponível em: https://doi.org/10.3390/ph14090856. Acesso em: 16 nov. 2024.
APA
Tomazi, R., Figueira, Â. C., Ferreira, A. M., Ferreira, D. Q., Souza, G. C. de, Pinheiro, W. B. de S., et al. (2021). Hypoglycemic activity of aqueous extract of latex from Hancornia speciosa Gomes: a study in Zebrafish and in silico. Pharmaceuticals, 14( 9), 1-29. doi:10.3390/ph14090856
NLM
Tomazi R, Figueira ÂC, Ferreira AM, Ferreira DQ, Souza GC de, Pinheiro WB de S, Pinheiro Neto JR, Silva GA da, Lima HB de, Hage-Melim LI da S, Pereira Filho ACM, Carvalho JCT, Almeida SSM da S de. Hypoglycemic activity of aqueous extract of latex from Hancornia speciosa Gomes: a study in Zebrafish and in silico [Internet]. Pharmaceuticals. 2021 ; 14( 9): 1-29.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ph14090856
Vancouver
Tomazi R, Figueira ÂC, Ferreira AM, Ferreira DQ, Souza GC de, Pinheiro WB de S, Pinheiro Neto JR, Silva GA da, Lima HB de, Hage-Melim LI da S, Pereira Filho ACM, Carvalho JCT, Almeida SSM da S de. Hypoglycemic activity of aqueous extract of latex from Hancornia speciosa Gomes: a study in Zebrafish and in silico [Internet]. Pharmaceuticals. 2021 ; 14( 9): 1-29.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ph14090856
Artigo de periodico
Effects of Baccharin isolated from Brazilian Green Propolis on adipocyte differentiation and hyperglycemia in ob/ob diabetic mice (2021)
Watanabe, Akio; Almeida, Marília Oliveira de ; Deguchi, Yusuke; Kozuka, Ryuzo; Arruda, Caroline ; Berreta, Andresa Aparecida; Bastos, Jairo Kenupp ; Woo, Je-Tae; Yonezawa, Takayuki
Source: International Journal of Molecular Sciences. Unidade: FCFRP
Subjects: PRÓPOLIS, DIABETES MELLITUS, ANTIDIABÉTICOS (HIPOGLICEMIANTES), GLICOSE, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WATANABE, Akio et al. Effects of Baccharin isolated from Brazilian Green Propolis on adipocyte differentiation and hyperglycemia in ob/ob diabetic mice. International Journal of Molecular Sciences, v. 22, n. 13, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22136954. Acesso em: 16 nov. 2024.
APA
Watanabe, A., Almeida, M. O. de, Deguchi, Y., Kozuka, R., Arruda, C., Berreta, A. A., et al. (2021). Effects of Baccharin isolated from Brazilian Green Propolis on adipocyte differentiation and hyperglycemia in ob/ob diabetic mice. International Journal of Molecular Sciences, 22( 13), 1-11. doi:10.3390/ijms22136954
NLM
Watanabe A, Almeida MO de, Deguchi Y, Kozuka R, Arruda C, Berreta AA, Bastos JK, Woo J-T, Yonezawa T. Effects of Baccharin isolated from Brazilian Green Propolis on adipocyte differentiation and hyperglycemia in ob/ob diabetic mice [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 13): 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ijms22136954
Vancouver
Watanabe A, Almeida MO de, Deguchi Y, Kozuka R, Arruda C, Berreta AA, Bastos JK, Woo J-T, Yonezawa T. Effects of Baccharin isolated from Brazilian Green Propolis on adipocyte differentiation and hyperglycemia in ob/ob diabetic mice [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 13): 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ijms22136954
Parte de monografia/livro
New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement (2020)
Couri, Carlos Eduardo Barra; Farias, Kelen Cristina Ribeiro Malmegrim de ; Rodrigues, Maria Carolina de Oliveira
Source: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Unidades: FCFRP, FMRP
Subjects: AUTOIMUNIDADE, CÉLULAS VEGETAIS, TRANSPLANTE DE ÓRGÃOS, BIOMARCADORES, DIABETES MELLITUS, TRANSPLANTE AUTÓLOGO, IMUNOSSUPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COURI, Carlos Eduardo Barra e FARIAS, Kelen Cristina Ribeiro Malmegrim de e RODRIGUES, Maria Carolina de Oliveira. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 16 nov. 2024.
APA
Couri, C. E. B., Farias, K. C. R. M. de, & Rodrigues, M. C. de O. (2020). New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9
NLM
Couri CEB, Farias KCRM de, Rodrigues MC de O. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Vancouver
Couri CEB, Farias KCRM de, Rodrigues MC de O. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Artigo de periodico
Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial (2020)
Fuchs, Flávio Danni; Scala, Luiz Cesar Nazario; Vilela-Martin, José Fernando; Whelton, Paul K.; Poli-de-Figueiredo, Carlos Eduardo; Pereira e Silva, Ricardo; Gus, Miguel; Bortolotto, Luiz Aparecido ; Consolim-Colombo, Fernanda M.; Schlatter, Rosane P.; Cesarino, Evandro José ; Castro, Iran; Figueiredo Neto, José Albuquerque de ; Chaves, Hilton; Steffens, André Avelino; Alves, João G.; Brandão, Andréa A.; Sousa, Marcos Roberto de; Jardim, Paulo C.; Moreira, Leila B.; Franco, Roberto S.; Gomes, Marco M.; Afiune Neto, Abrahão; Fuchs, Fernando Carlos; Sobral Filho, Dario C; Nóbrega, Antônio C.; Nobre, Fernando; Berwanger, Otávio; Fuchs, Sandra C
Source: Acta Diabetologica. Unidades: FM, FCFRP
Subjects: HIPERTENSÃO, DIABETES MELLITUS, FÁRMACOS DIURÉTICOS, RECEPTORES DE ANGIOTENSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUCHS, Flávio Danni et al. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial. Acta Diabetologica, v. 58, n. 2, p. 215-220, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00592-020-01611-8. Acesso em: 16 nov. 2024.
APA
Fuchs, F. D., Scala, L. C. N., Vilela-Martin, J. F., Whelton, P. K., Poli-de-Figueiredo, C. E., Pereira e Silva, R., et al. (2020). Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial. Acta Diabetologica, 58( 2), 215-220. doi:10.1007/s00592-020-01611-8
NLM
Fuchs FD, Scala LCN, Vilela-Martin JF, Whelton PK, Poli-de-Figueiredo CE, Pereira e Silva R, Gus M, Bortolotto LA, Consolim-Colombo FM, Schlatter RP, Cesarino EJ, Castro I, Figueiredo Neto JA de, Chaves H, Steffens AA, Alves JG, Brandão AA, Sousa MR de, Jardim PC, Moreira LB, Franco RS, Gomes MM, Afiune Neto A, Fuchs FC, Sobral Filho DC, Nóbrega AC, Nobre F, Berwanger O, Fuchs SC. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial [Internet]. Acta Diabetologica. 2020 ; 58( 2): 215-220.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00592-020-01611-8
Vancouver
Fuchs FD, Scala LCN, Vilela-Martin JF, Whelton PK, Poli-de-Figueiredo CE, Pereira e Silva R, Gus M, Bortolotto LA, Consolim-Colombo FM, Schlatter RP, Cesarino EJ, Castro I, Figueiredo Neto JA de, Chaves H, Steffens AA, Alves JG, Brandão AA, Sousa MR de, Jardim PC, Moreira LB, Franco RS, Gomes MM, Afiune Neto A, Fuchs FC, Sobral Filho DC, Nóbrega AC, Nobre F, Berwanger O, Fuchs SC. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial [Internet]. Acta Diabetologica. 2020 ; 58( 2): 215-220.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00592-020-01611-8
Tese (Doutorado)
Impacto da deficiência do gene da galectina-1 no diabetes mellitus experimental induzido por estreptozotocina (2020)
Santos, Tálita Pollyanna Moreira dos; Baruffi, Marcelo Dias (Orientador)
Unidade: FCFRP
Subjects: DIABETES MELLITUS, CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA, ESPECTROMETRIA DE MASSAS, PROTEÍNAS, DOENÇAS AUTOIMUNES, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Tálita Pollyanna Moreira dos. Impacto da deficiência do gene da galectina-1 no diabetes mellitus experimental induzido por estreptozotocina. 2020. Tese (Doutorado) – Universidade de São Paulo, Ribeirão Preto, 2020. Disponível em: https://www.teses.usp.br/teses/disponiveis/60/60140/tde-22092021-085646/. Acesso em: 16 nov. 2024.
APA
Santos, T. P. M. dos. (2020). Impacto da deficiência do gene da galectina-1 no diabetes mellitus experimental induzido por estreptozotocina (Tese (Doutorado). Universidade de São Paulo, Ribeirão Preto. Recuperado de https://www.teses.usp.br/teses/disponiveis/60/60140/tde-22092021-085646/
NLM
Santos TPM dos. Impacto da deficiência do gene da galectina-1 no diabetes mellitus experimental induzido por estreptozotocina [Internet]. 2020 ;[citado 2024 nov. 16 ] Available from: https://www.teses.usp.br/teses/disponiveis/60/60140/tde-22092021-085646/
Vancouver
Santos TPM dos. Impacto da deficiência do gene da galectina-1 no diabetes mellitus experimental induzido por estreptozotocina [Internet]. 2020 ;[citado 2024 nov. 16 ] Available from: https://www.teses.usp.br/teses/disponiveis/60/60140/tde-22092021-085646/
Artigo de periodico
NOD2 deficiency promotes intestinal CD4+ T lymphocyte imbalance, metainflammation, and aggravates Type 2 Diabetes in murine model (2020)
Sartori, Daniela Carlos ; Pérez, Malena Martínez ; Leite, Jefferson Antonio; Rocha, Fernanda Agostini; Martins, Larissa Marfori Sampaio; Pereira, Camila André; Silva, Thais Fernanda de Campos Fraga da ; Pucci, Taís Andrade; Ramos, Simone Gusmão ; Câmara, Niels Olsen Saraiva ; Bonato, Vânia Luiza Deperon ; Passaglia, Rita de Cassia Aleixo Tostes ; Silva, João Santana da
Source: Frontiers in Immunology. Unidades: FMRP, ICB, FCFRP
Subjects: IMUNOLOGIA, LINFÓCITOS T, DIABETES MELLITUS, INFLAMAÇÃO, OBESIDADE, ADIPOSIDADE, CAMUNDONGOS, RESISTÊNCIA À INSULINA, HIPERGLICEMIA, LINFONODOS DE ANIMAL, EXPRESSÃO GÊNICA, BACTÉRIAS GRAM-NEGATIVAS, BACTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARTORI, Daniela Carlos et al. NOD2 deficiency promotes intestinal CD4+ T lymphocyte imbalance, metainflammation, and aggravates Type 2 Diabetes in murine model. Frontiers in Immunology, v. 11, p. 16 , 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.01265. Acesso em: 16 nov. 2024.
APA
Sartori, D. C., Pérez, M. M., Leite, J. A., Rocha, F. A., Martins, L. M. S., Pereira, C. A., et al. (2020). NOD2 deficiency promotes intestinal CD4+ T lymphocyte imbalance, metainflammation, and aggravates Type 2 Diabetes in murine model. Frontiers in Immunology, 11, 16 . doi:10.3389/fimmu.2020.01265
NLM
Sartori DC, Pérez MM, Leite JA, Rocha FA, Martins LMS, Pereira CA, Silva TF de CF da, Pucci TA, Ramos SG, Câmara NOS, Bonato VLD, Passaglia R de CAT, Silva JS da. NOD2 deficiency promotes intestinal CD4+ T lymphocyte imbalance, metainflammation, and aggravates Type 2 Diabetes in murine model [Internet]. Frontiers in Immunology. 2020 ; 11 16 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fimmu.2020.01265
Vancouver
Sartori DC, Pérez MM, Leite JA, Rocha FA, Martins LMS, Pereira CA, Silva TF de CF da, Pucci TA, Ramos SG, Câmara NOS, Bonato VLD, Passaglia R de CAT, Silva JS da. NOD2 deficiency promotes intestinal CD4+ T lymphocyte imbalance, metainflammation, and aggravates Type 2 Diabetes in murine model [Internet]. Frontiers in Immunology. 2020 ; 11 16 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fimmu.2020.01265
Artigo de periodico
Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus (2019)
Gonçalves, Ana Carolina Oliveira; Cazarim, Maurilio de Souza ; Sanches, Cristina; Pereira, Leonardo Régis Leira ; Camargos, Ana Márcia Tomé; Aquino, Jéssica Azevedo; Baldoni, André Oliveira
Source: BMJ Open Diabetes Research & Care. Unidade: FCFRP
Subjects: DIABETES MELLITUS, CUSTOS DE MEDICAMENTOS, CUSTOS DOS CUIDADOS DE SAÚDE, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Ana Carolina Oliveira et al. Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus. BMJ Open Diabetes Research & Care, v. 7, p. e000647, 2019Tradução . . Disponível em: https://doi.org/10.1136/bmjdrc-2018-000647. Acesso em: 16 nov. 2024.
APA
Gonçalves, A. C. O., Cazarim, M. de S., Sanches, C., Pereira, L. R. L., Camargos, A. M. T., Aquino, J. A., & Baldoni, A. O. (2019). Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus. BMJ Open Diabetes Research & Care, 7, e000647. doi:10.1136/bmjdrc-2018-000647
NLM
Gonçalves ACO, Cazarim M de S, Sanches C, Pereira LRL, Camargos AMT, Aquino JA, Baldoni AO. Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus [Internet]. BMJ Open Diabetes Research & Care. 2019 ; 7 e000647.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1136/bmjdrc-2018-000647
Vancouver
Gonçalves ACO, Cazarim M de S, Sanches C, Pereira LRL, Camargos AMT, Aquino JA, Baldoni AO. Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus [Internet]. BMJ Open Diabetes Research & Care. 2019 ; 7 e000647.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1136/bmjdrc-2018-000647
Artigo de periodico
DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes (2019)
Davanso, Mariana Rodrigues; Caliári Oliveira, Carolina; Couri, Carlos Eduardo Barra; Covas, Dimas Tadeu ; Leal, Ângela Merice de Oliveira; Voltarelli, Julio Cesar; Farias, Kelen Cristina Ribeiro Malmegrim de ; Yaochite, Juliana Navarro Ueda
Source: Inflammation. Unidades: FMRP, FCFRP
Subjects: PÂNCREAS, DIABETES MELLITUS, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAVANSO, Mariana Rodrigues et al. DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes. Inflammation, v. 42, n. 2, p. 449-462, 2019Tradução . . Disponível em: https://doi.org/10.1007/s10753-018-00954-3. Acesso em: 16 nov. 2024.
APA
Davanso, M. R., Caliári Oliveira, C., Couri, C. E. B., Covas, D. T., Leal, Â. M. de O., Voltarelli, J. C., et al. (2019). DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes. Inflammation, 42( 2), 449-462. doi:10.1007/s10753-018-00954-3
NLM
Davanso MR, Caliári Oliveira C, Couri CEB, Covas DT, Leal ÂM de O, Voltarelli JC, Farias KCRM de, Yaochite JNU. DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes [Internet]. Inflammation. 2019 ; 42( 2): 449-462.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10753-018-00954-3
Vancouver
Davanso MR, Caliári Oliveira C, Couri CEB, Covas DT, Leal ÂM de O, Voltarelli JC, Farias KCRM de, Yaochite JNU. DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes [Internet]. Inflammation. 2019 ; 42( 2): 449-462.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10753-018-00954-3
Artigo de periodico
Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy (2019)
Saboia, Jaquellyne Gurgel Penaforte; Couri, Carlos Eduardo Barra; Fernandes, Virginia Oliveira; Montenegro, Ana Paula Dias Rangel; Batista, Lívia Aline de Araújo; Zajdenverg, Lenita; Negrato, Carlos Antonio ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Moraes, Daniela Aparecida de; Dias, Juliana Bernardes Elias; Oliveira, Maria Carolina ; Hussain, Akhtar; Gomes, Marilia Brito ; Montenegro Junior, Renan Magalhães
Source: Frontiers in Endocrinology. Unidades: FCFRP, FMRP
Subjects: INSULINA, DIABETES MELLITUS, TRANSPLANTES, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABOIA, Jaquellyne Gurgel Penaforte et al. Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy. Frontiers in Endocrinology, v. 10, p. [7] , 2019Tradução . . Disponível em: https://doi.org/10.3389/fendo.2019.00747. Acesso em: 16 nov. 2024.
APA
Saboia, J. G. P., Couri, C. E. B., Fernandes, V. O., Montenegro, A. P. D. R., Batista, L. A. de A., Zajdenverg, L., et al. (2019). Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy. Frontiers in Endocrinology, 10, [7] . doi:10.3389/fendo.2019.00747
NLM
Saboia JGP, Couri CEB, Fernandes VO, Montenegro APDR, Batista LA de A, Zajdenverg L, Negrato CA, Farias KCRM de, Moraes DA de, Dias JBE, Oliveira MC, Hussain A, Gomes MB, Montenegro Junior RM. Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy [Internet]. Frontiers in Endocrinology. 2019 ; 10 [7] .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fendo.2019.00747
Vancouver
Saboia JGP, Couri CEB, Fernandes VO, Montenegro APDR, Batista LA de A, Zajdenverg L, Negrato CA, Farias KCRM de, Moraes DA de, Dias JBE, Oliveira MC, Hussain A, Gomes MB, Montenegro Junior RM. Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy [Internet]. Frontiers in Endocrinology. 2019 ; 10 [7] .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fendo.2019.00747
Artigo de periodico
Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin (2019)
Godoy, Ana Leonor Pardo Campos; Moraes, Natália Valadares de; Benzi, Jhohann Richard de Lima ; Lanchote, Vera Lucia
Source: European Journal of Pharmaceutical Sciences. Unidade: FCFRP
Subjects: DIABETES MELLITUS, ANALGÉSICOS, GLICOSE, INSULINA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Ana Leonor Pardo Campos et al. Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin. European Journal of Pharmaceutical Sciences, v. 128, p. 97-102, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2018.11.032. Acesso em: 16 nov. 2024.
APA
Godoy, A. L. P. C., Moraes, N. V. de, Benzi, J. R. de L., & Lanchote, V. L. (2019). Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin. European Journal of Pharmaceutical Sciences, 128, 97-102. doi:10.1016/j.ejps.2018.11.032
NLM
Godoy ALPC, Moraes NV de, Benzi JR de L, Lanchote VL. Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin [Internet]. European Journal of Pharmaceutical Sciences. 2019 ; 128 97-102.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ejps.2018.11.032
Vancouver
Godoy ALPC, Moraes NV de, Benzi JR de L, Lanchote VL. Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin [Internet]. European Journal of Pharmaceutical Sciences. 2019 ; 128 97-102.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ejps.2018.11.032
Tese (Doutorado)
Avaliação de formulações a base de fibroína da seda e insulina no tratamento tópico de feridas oculares (2019)
Cubayachi, Camila; Lopez, Renata Fonseca Vianna (Orientador)
Unidade: FCFRP
Subjects: DOENÇAS DA CÓRNEA, DIABETES MELLITUS, INSULINA, CICATRIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUBAYACHI, Camila. Avaliação de formulações a base de fibroína da seda e insulina no tratamento tópico de feridas oculares. 2019. Tese (Doutorado) – Universidade de São Paulo, Ribeirão Preto, 2019. Disponível em: http://www.teses.usp.br/teses/disponiveis/60/60137/tde-04092019-092934/. Acesso em: 16 nov. 2024.
APA
Cubayachi, C. (2019). Avaliação de formulações a base de fibroína da seda e insulina no tratamento tópico de feridas oculares (Tese (Doutorado). Universidade de São Paulo, Ribeirão Preto. Recuperado de http://www.teses.usp.br/teses/disponiveis/60/60137/tde-04092019-092934/
NLM
Cubayachi C. Avaliação de formulações a base de fibroína da seda e insulina no tratamento tópico de feridas oculares [Internet]. 2019 ;[citado 2024 nov. 16 ] Available from: http://www.teses.usp.br/teses/disponiveis/60/60137/tde-04092019-092934/
Vancouver
Cubayachi C. Avaliação de formulações a base de fibroína da seda e insulina no tratamento tópico de feridas oculares [Internet]. 2019 ;[citado 2024 nov. 16 ] Available from: http://www.teses.usp.br/teses/disponiveis/60/60137/tde-04092019-092934/
Artigo de periodico-carta/editorial
Teplizumab in relatives at risk for type 1 diabetes. [Carta] (2019)
Couri, Carlos Eduardo Barra; Farias, Kelen Cristina Ribeiro Malmegrim de ; Oliveira, Maria Carolina
Source: New England Journal of Medicine. Unidades: FCFRP, FMRP
Subjects: DIABETES MELLITUS, ANTICORPOS, LINFÓCITOS T, INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COURI, Carlos Eduardo Barra e FARIAS, Kelen Cristina Ribeiro Malmegrim de e OLIVEIRA, Maria Carolina. Teplizumab in relatives at risk for type 1 diabetes. [Carta]. New England Journal of Medicine. Waltham: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1056/NEJMc1912500. Acesso em: 16 nov. 2024. , 2019
APA
Couri, C. E. B., Farias, K. C. R. M. de, & Oliveira, M. C. (2019). Teplizumab in relatives at risk for type 1 diabetes. [Carta]. New England Journal of Medicine. Waltham: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1056/NEJMc1912500
NLM
Couri CEB, Farias KCRM de, Oliveira MC. Teplizumab in relatives at risk for type 1 diabetes. [Carta] [Internet]. New England Journal of Medicine. 2019 ; 381( 19): 1879-1881.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1056/NEJMc1912500
Vancouver
Couri CEB, Farias KCRM de, Oliveira MC. Teplizumab in relatives at risk for type 1 diabetes. [Carta] [Internet]. New England Journal of Medicine. 2019 ; 381( 19): 1879-1881.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1056/NEJMc1912500

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration

Área de concentração